Upon silencing CCAT1, expression of p-MAPK1 and MYC was significantly decreased indicating that a positive feedback loop exists among CCAT1/miR-490-3P/MAPK1/MYC in AML cells and therefore provided new candidates for future research and treatment of AML (145). Here, MAPK1 is linked to acute myeloid leukemia.